Cleveland Clinic has received a $750,000 grant from the Cleveland Foundation to establish the Leonard Krieger Chair in Preventive Cardiology. Stanley L. Hazen, MD, PhD, will be the first to hold the chair.
Hazen's research spans from studying mechanisms involved in the development of cardiovascular disease to identifying noninvasive testing for asthma. Recently, he published a paper in Nature on gut flora as a participant and therapeutic target in cardiovascular disease.
"We will focus on development of an inhibitor of a recently discovered gut flora pathway as a new therapy for the treatment of atherosclerosis," Hazen said.
Hazen is currently the head of the section for preventive cardiology and rehabilitation, director for the Center for Cardiovascular Diagnostics and Prevention, director of the Cleveland Clinic Mass Spectrometry Core Facilities and the Robert and Suzanne Tomsich department of cardiovascular medicine at Cleveland Clinic. He is also the vice-chair of translational research for the Lerner Research Institute at the Cleveland Clinic.